Carregant...
Emicizumab in the Treatment of Acquired Haemophilia: A Case Report
The prognosis of acquired haemophilia A (AHA) is severe and treatment options are limited. Emicizumab is a novel bispecific humanized monoclonal antibody in the treatment of inherited AHA with inhibitors. An 83-year-old AHA patient with congestive heart failure and a high risk for thromboembolic and...
Guardat en:
| Publicat a: | Transfus Med Hemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514512/ https://ncbi.nlm.nih.gov/pubmed/31191199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000497287 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|